Hereditary persistence of fetal hemoglobin (HPFH) is a non-fatal condition in which adults produce fetal hemoglobin throughout adulthood. Because sickle cell anemia is ameliorated by the presence of fetal hemoglobin, HPFH is believed to be an identifiable modifier locus for other blood disorders such as sickle cell anemia and thalassemia. A series of families in Sardinia that display HPFH were previously genotyped with genetic markers from the candidate regions for the trait, chromosomes 6 and X. After linkage analysis, flanking markers for both candidate regions were genotyped and subsequent statistical analyses were performed, suggesting the need for additional genotyping in a larger sample.

Agency
National Institute of Health (NIH)
Institute
National Human Genome Research Institute (NHGRI)
Type
Intramural Research (Z01)
Project #
1Z01HG000204-01
Application #
6681713
Study Section
(IDRB)
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Human Genome Research
Department
Type
DUNS #
City
State
Country
United States
Zip Code